Transforming growth factor-beta regulates production of proteoglycans by mesangial cells - PubMed (original) (raw)
Review
doi: 10.1038/ki.1990.35.
Affiliations
- PMID: 2407884
- DOI: 10.1038/ki.1990.35
Free article
Review
Transforming growth factor-beta regulates production of proteoglycans by mesangial cells
W A Border et al. Kidney Int. 1990 Feb.
Free article
Abstract
Accumulation of glomerular extracellular matrix is a prominent feature of most forms of progressive glomerular disease. Since some growth factors may play a role in extracellular matrix production, we examined the effects of transforming growth factor-beta (TGF-beta), interleukin 1, platelet derived growth factor, and tumor necrosis factor on the production of extracellular matrix components by cultured rat mesangial cells. In control experiments we found that mesangial cells produced two distinct proteoglycans identified as the small chondroitin/dermatan sulfate proteoglycans biglycan (PG I) and decorin (PG II) by showing that their mobility on SDS-PAGE changed upon digestion by chondroitinase ABC, and that they reacted with antibodies raised against synthetic peptides from the core protein sequence of human biglycan and decorin. Exposure to TGF-beta for 48 hours stimulated an 8- to 10-fold increase in the biglycan and decorin bands, and induced a structural change detected as a shift in electrophoretic mobility. TGF-beta did not demonstrably affect the production of other matrix proteins by the mesangial cells. The other growth factors tested had no comparable effect on the production of proteoglycans or other extracellular matrix components by these cells. Our results show that TGF-beta is unique among growth factors in its regulatory effects on mesangial cell proteoglycan production. The release or activation of TGF-beta during glomerular injury could mediate the accumulation of proteoglycans in the extracellular matrix and predispose the kidney to development of glomerulosclerosis.
Similar articles
- Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1.
Nakamura T, Miller D, Ruoslahti E, Border WA. Nakamura T, et al. Kidney Int. 1992 May;41(5):1213-21. doi: 10.1038/ki.1992.183. Kidney Int. 1992. PMID: 1614036 - Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican.
Schaefer L, Gröne HJ, Raslik I, Robenek H, Ugorcakova J, Budny S, Schaefer RM, Kresse H. Schaefer L, et al. Kidney Int. 2000 Oct;58(4):1557-68. doi: 10.1046/j.1523-1755.2000.00317.x. Kidney Int. 2000. PMID: 11012890 - Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
Border WA, Ruoslahti E. Border WA, et al. Cell Differ Dev. 1990 Dec 2;32(3):425-31. doi: 10.1016/0922-3371(90)90059-6. Cell Differ Dev. 1990. PMID: 2099240 Review. - Role of TGF-beta 1 in experimental glomerulonephritis.
Border WA, Okuda S, Nakamura T, Languino LR, Ruoslahti E. Border WA, et al. Ciba Found Symp. 1991;157:178-89; discussion 189-93. Ciba Found Symp. 1991. PMID: 2070683 Review.
Cited by
- Decorin impeded the advancement of thyroid papillary carcinoma by thwarting the EGFR/ FER/ SHP2 signaling-induced sustenance of early endosomes.
Liu Y, Xin Y, Lv T, Chang Z, Xue G, Shang X. Liu Y, et al. Heliyon. 2024 Jun 20;10(13):e33358. doi: 10.1016/j.heliyon.2024.e33358. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39035505 Free PMC article. - Alantolactone Attenuates Renal Fibrosis via Inhibition of Transforming Growth Factor β/Smad3 Signaling Pathway.
Lee KM, Hwang YJ, Jung GS. Lee KM, et al. Diabetes Metab J. 2024 Jan;48(1):72-82. doi: 10.4093/dmj.2022.0231. Epub 2024 Jan 3. Diabetes Metab J. 2024. PMID: 38173367 Free PMC article. - Role of Decorin in the Lens and Ocular Diseases.
Kubo E, Shibata S, Shibata T, Sasaki H, Singh DP. Kubo E, et al. Cells. 2022 Dec 24;12(1):74. doi: 10.3390/cells12010074. Cells. 2022. PMID: 36611867 Free PMC article. Review. - Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?
Xiao Y, Vazquez-Padron RI, Martinez L, Singer HA, Woltmann D, Salman LH. Xiao Y, et al. J Vasc Access. 2024 Mar;25(2):390-406. doi: 10.1177/11297298221085458. Epub 2022 Jun 24. J Vasc Access. 2024. PMID: 35751379 Free PMC article. Review. - Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury.
Nakamura T, Bonnard B, Palacios-Ramirez R, Fernández-Celis A, Jaisser F, López-Andrés N. Nakamura T, et al. Int J Mol Sci. 2022 Jun 15;23(12):6680. doi: 10.3390/ijms23126680. Int J Mol Sci. 2022. PMID: 35743123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources